Maria L Dowell1, Tera L Lavoie, Julian Solway, Ramaswamy Krishnan. 1. aDepartment of Medicine bDepartment of Pediatrics, University of Chicago, Chicago, Illinois, USA cCenter for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Asthma is a major public health problem that afflicts nearly one in 20 people worldwide. Despite available treatments, asthma symptoms remain poorly controlled in a significant minority of asthma patients, especially those with severe disease. Accordingly, much ongoing effort has been directed at developing new therapeutic strategies; these efforts are described in detail below. RECENT FINDINGS: Although mucus hypersecretion is an important component of asthma pathobiology, the primary mechanism of morbidity and mortality in asthma is excessive narrowing of the airway. The key end- effector of excessive airway narrowing is airway smooth muscle (ASM) contraction; overcoming ASM contraction is therefore a prominent therapeutic strategy. Here, we review exciting new advances aimed at ASM relaxation. SUMMARY: Exciting advances in ASM biology have identified new therapeutic targets for the prevention or reversal of bronchoconstriction in asthma.
PURPOSE OF REVIEW: Asthma is a major public health problem that afflicts nearly one in 20 people worldwide. Despite available treatments, asthma symptoms remain poorly controlled in a significant minority of asthmapatients, especially those with severe disease. Accordingly, much ongoing effort has been directed at developing new therapeutic strategies; these efforts are described in detail below. RECENT FINDINGS: Although mucus hypersecretion is an important component of asthma pathobiology, the primary mechanism of morbidity and mortality in asthma is excessive narrowing of the airway. The key end- effector of excessive airway narrowing is airway smooth muscle (ASM) contraction; overcoming ASM contraction is therefore a prominent therapeutic strategy. Here, we review exciting new advances aimed at ASM relaxation. SUMMARY: Exciting advances in ASM biology have identified new therapeutic targets for the prevention or reversal of bronchoconstriction in asthma.
Authors: Serena Sirigu; James J Hartman; Vicente José Planelles-Herrero; Virginie Ropars; Sheila Clancy; Xi Wang; Grace Chuang; Xiangping Qian; Pu-Ping Lu; Edward Barrett; Karin Rudolph; Christopher Royer; Bradley P Morgan; Enrico A Stura; Fady I Malik; Anne M Houdusse Journal: Proc Natl Acad Sci U S A Date: 2016-11-04 Impact factor: 11.205
Authors: Giusy D Albano; Jinming Zhao; Emily B Etling; Seo Young Park; Haizhen Hu; John B Trudeau; Mirella Profita; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2015-03-24 Impact factor: 10.793
Authors: David C Adams; Jasmin A Holz; Margit V Szabari; Lida P Hariri; Andrew F Mccrossan; Christopher J Manley; Sean Fleury; Seamus O'Shaughnessy; Jason Weiner; Melissa J Suter Journal: J Appl Physiol (1985) Date: 2021-04-22
Authors: Punnam Chander Veerati; Jennifer A Mitchel; Andrew T Reid; Darryl A Knight; Nathan W Bartlett; Jin-Ah Park; Chris L Grainge Journal: Eur Respir Rev Date: 2020-08-04